TransMedics Group, Inc. (TMDX)
91.31
-0.07
(-0.08%)
USD |
NASDAQ |
Nov 16, 11:59
TransMedics Group Enterprise Value : 3.547B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.547B |
| November 12, 2026 | 3.568B |
| November 11, 2026 | 3.569B |
| November 10, 2026 | 3.532B |
| November 09, 2026 | 3.631B |
| November 06, 2026 | 3.438B |
| November 05, 2026 | 2.769B |
| November 04, 2026 | 2.900B |
| November 03, 2026 | 2.712B |
| November 02, 2026 | 2.689B |
| October 30, 2026 | 2.665B |
| October 29, 2026 | 2.705B |
| October 28, 2026 | 2.697B |
| October 27, 2026 | 2.795B |
| October 26, 2026 | 2.826B |
| October 23, 2026 | 2.830B |
| October 22, 2026 | 2.876B |
| October 21, 2026 | 2.888B |
| October 20, 2026 | 2.969B |
| October 19, 2026 | 2.860B |
| October 16, 2026 | 2.832B |
| October 15, 2026 | 3.031B |
| October 14, 2026 | 2.996B |
| October 13, 2026 | 3.122B |
| October 12, 2026 | 3.088B |
| Date | Value |
|---|---|
| October 09, 2026 | 3.078B |
| October 08, 2026 | 3.117B |
| October 07, 2026 | 3.189B |
| October 06, 2026 | 3.161B |
| October 05, 2026 | 3.256B |
| October 02, 2026 | 3.145B |
| October 01, 2026 | 3.105B |
| September 30, 2026 | 3.272B |
| September 29, 2026 | 3.306B |
| September 28, 2026 | 3.260B |
| September 25, 2026 | 3.349B |
| September 24, 2026 | 3.300B |
| September 23, 2026 | 3.408B |
| September 22, 2026 | 3.445B |
| September 21, 2026 | 3.418B |
| September 18, 2026 | 3.388B |
| September 17, 2026 | 3.396B |
| September 16, 2026 | 3.427B |
| September 15, 2026 | 3.446B |
| September 14, 2026 | 3.368B |
| September 11, 2026 | 3.241B |
| September 10, 2026 | 3.340B |
| September 09, 2026 | 3.387B |
| September 08, 2026 | 3.452B |
| September 04, 2026 | 3.511B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp. | 75.80B |
| Insulet Corp. | 10.95B |
| Abbott Laboratories | 215.41B |
| Baxter International, Inc. | 19.36B |
| Becton, Dickinson & Co. | 74.72B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 17.07M |
| Revenue (Quarterly) | 203.00M |
| Total Expenses (Quarterly) | 185.93M |
| EPS Diluted (Quarterly) | 0.4631 |
| Gross Profit Margin (Quarterly) | 56.20% |
| Profit Margin (Quarterly) | 8.41% |
| Earnings Yield | 3.99% |
| Operating Earnings Yield | 2.41% |
| Normalized Earnings Yield | 4.007 |